ACCESSION: MSBNK-SMB_Measured-HSA032P0253003
RECORD_TITLE: Annotated; Histidinyl-Proline; LC-ESI-QTOF; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.25, Processed 2025.02.25, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 15.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 60
COMMENT: NUM_AVERAGED_SPEC 10
COMMENT: RAW_SPEC {'RA8-pos_421': {'bp': 3720.0, 'sum': 6283.0}, 'RA26-pos_404': {'bp': 3207.0, 'sum': 5890.0}, 'HC8-pos_414': {'bp': 2998.0, 'sum': 4578.0}, 'HC5-pos_423': {'bp': 2375.0, 'sum': 5623.0}, 'HC10-pos_408': {'bp': 2366.0, 'sum': 4658.0}, 'HC17-pos_415': {'bp': 2269.0, 'sum': 3848.0}, 'HC25-pos_411': {'bp': 2042.0, 'sum': 4028.0}, 'RA24-pos_404': {'bp': 1612.0, 'sum': 3702.0}, 'RA13-pos_446': {'bp': 1445.0, 'sum': 2566.0}, 'RA21-pos_418': {'bp': 1341.0, 'sum': 2411.0}}
COMMENT: RETENTION_TIME_STDEV 0.006
COMMENT: PRECURSOR_M/Z_RAW 253.127487
COMMENT: PRECURSOR_M/Z_STDEV 0.000851
COMMENT: PRECURSOR_IN_MS1 mz 253.128172; int 61.899; delta(ppm) 12.250876
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 11.939; C9H21N2O4P; [M+H]+; delta(ppm) -11.938718
COMMENT: PROPOSED_MF SevenGoldenRules 5.386; C11H16N4O3; [M+H]+; delta(ppm) -5.386305
COMMENT: PROPOSED_MF SevenGoldenRules 0.083; C10H20O7; [M+H]+; delta(ppm) -0.083293
COMMENT: PROPOSED_MF SevenGoldenRules 4.803; C14H22P2; [M+H]+; delta(ppm) 4.803251
COMMENT: PROPOSED_MF MS-FINDER 3.600; C11H16N4O3; [M+H]+; delta(ppm) -5.368153
COMMENT: PROPOSED_MF MS-FINDER 2.631; C6H16N6O5; [M+H]+; delta(ppm) 10.524042
COMMENT: PROPOSED_MF MS-FINDER 2.452; C5H17N8O2P; [M+H]+; delta(ppm) -1.285029
COMMENT: PROPOSED_MF MS-FINDER 2.232; C7H12N10O; [M+H]+; delta(ppm) 5.240414
COMMENT: PROPOSED_MF MS-FINDER 2.026; C6H24N2O4S2; [M+H]+; delta(ppm) 12.374516
COMMENT: PROPOSED_MF MS-FINDER 2.026; C9H21N2O4P; [M+H]+; delta(ppm) -11.893457
COMMENT: PROPOSED_MF MS-FINDER 2.021; C10H20O7; [M+H]+; delta(ppm) -0.084637
COMMENT: PROPOSED_MF MS-FINDER 1.983; C7H20N6S2; [M+H]+; delta(ppm) 7.090868
COMMENT: PROPOSED_MF MS-FINDER 1.367; C11H24O2S2; [M+H]+; delta(ppm) -3.517737
COMMENT: PROPOSED_MF MS-FINDER 1.166; C14H20O2S; [M+H]+; delta(ppm) 9.800215
COMMENT: PROPOSED_MF SIRIUS5_Sirius 12.159; C11H16N4O3; [M+H]+; delta(ppm) -5.368153
COMMENT: PROPOSED_MF SIRIUS5_Sirius 7.631; C10H20O7; [M+H]+; delta(ppm) -0.084637
COMMENT: PROPOSED_MF SIRIUS5_Sirius 1.997; C14H20O2S; [M+H]+; delta(ppm) 9.800215
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.999; C11H16N4O3; [M+H]+; delta(ppm) -5.368153
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.001; C10H20O7; [M+H]+; delta(ppm) -0.084637
COMMENT: PROPOSED_MF SIRIUS6_Sirius 18.627; C11H16N4O3; [M+H]+; delta(ppm) -5.368153
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.661; C8H17FN4O4; [M+H]+; delta(ppm) -9.882216
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.387; C12H14F2N4; [M+H]+; delta(ppm) 8.806257
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.825; C10H20O7; [M+H]+; delta(ppm) -0.084637
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.589; C7H12N10O; [M+H]+; delta(ppm) 5.240414
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.174; C9H15F3N4O; [M+H]+; delta(ppm) 4.292066
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.575; C5H17N8O2P; [M+H]+; delta(ppm) -1.285029
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.250; C4H13FN10O2; [M+H]+; delta(ppm) 0.726255
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.461; C10H24O3SSi; [M+H]+; delta(ppm) -201672.207076
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.388; C9H14N7O2; [M+H]+; delta(ppm) -0.063898
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C11H16N4O3; [M+H]+; delta(ppm) -5.368153
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 3.000; LNCFUHAPNTYMJB-IUCAKERBSA-N; C11H16N4O3; Spectral Match to His-Pro from NIST14
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.133; LNCFUHAPNTYMJB-UHFFFAOYNA-N; [M+H]+; NC(CC1=CN=CN1)C(=O)N1CCCC1C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.307; BEPSGCXDIVACBU-UHFFFAOYNA-N; [M+H]+; OC(=O)C(CC1=CN=CN1)NC(=O)C1CCCN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.128; KETCWQQGXIYFBX-UHFFFAOYSA-N; [M+H]+; O=S(=O)(NCC1OCC(NC(C)C)C1O)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.059; CPMCGGSHBSNTOY-UHFFFAOYNA-N; [M+H]+; CN=C(NCCSCC1N=CN=C1C)NC#N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.059; AQIXAKUUQRKLND-UHFFFAOYSA-N; [M+H]+; C\N=C(\NCCSCC1=C(C)NC=N1)NC#N
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.801; LNCFUHAPNTYMJB-UHFFFAOYNA-N; [M+H]+; Histidinyl-Proline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.469; BEPSGCXDIVACBU-UHFFFAOYNA-N; [M+H]+; Prolyl-Histidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.561; GDEAMEURJBBCOQ-UHFFFAOYSA-N; [M+H]+; pirimicarb-desmethyl formamido
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.902; SWLJVDNUQDIJCV-UHFFFAOYSA-N; [M+H]+; 6-(cyclohexylamino)-3-methyl-5-nitroso-1H-pyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; LNCFUHAPNTYMJB-UHFFFAOYNA-N; [M+H]+; Histidinyl-Proline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ZLXYJEYKAQYNPV-UHFFFAOYNA-N; [M+H]+; 2,3-Butanediol glucoside
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; DRAGHEYLLOEQHM-ZPWRHOESNA-N; [M+H]+; UNPD7414
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.548; BEPSGCXDIVACBU-UHFFFAOYNA-N; [M+H]+; Prolyl-Histidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.406; GDEAMEURJBBCOQ-UHFFFAOYSA-N; [M+H]+; pirimicarb-desmethyl formamido
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; SWLJVDNUQDIJCV-UHFFFAOYSA-N; [M+H]+; 6-(cyclohexylamino)-3-methyl-5-nitroso-1H-pyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; HAFMWBNGZQAGCH-UHFFFAOYSA-N; [M+H]+; UNPD159433
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.750; LNCFUHAPNTYMJB-IUCAKERBSA-N; [M+H]+; (2S)-1-[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; ZLXYJEYKAQYNPV-UHFFFAOYSA-N; [M+H]+; 2-(3-hydroxybutan-2-yloxy)-6-(hydroxymethyl)oxane-3,4,5-triol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.677; BEPSGCXDIVACBU-UHFFFAOYSA-N; [M+H]+; 3-(1H-imidazol-5-yl)-2-(pyrrolidine-2-carbonylamino)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.406; GDEAMEURJBBCOQ-UHFFFAOYSA-N; [M+H]+; [2-[formyl(methyl)amino]-5,6-dimethylpyrimidin-4-yl] N,N-dimethylcarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.836; NIAMBTSPHJKHDH-UHFFFAOYSA-N; [M+H]+; 8-(4-hydroxybutyl)-1,3-dimethyl-7H-purine-2,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.827; SURBHXJZUCWWOG-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-formyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine-7-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.786; LMVCFASVYSOENM-UHFFFAOYSA-N; [M+H]+; 1-(2,5-dimethoxyphenyl)-3-(N'-methylcarbamimidoyl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.786; FJKXMUQYTLJEJF-UHFFFAOYSA-N; [M+H]+; 1-(2,4-dimethoxyphenyl)-3-(N'-methylcarbamimidoyl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.786; QEOUJXWBKWXEMX-UHFFFAOYSA-N; [M+H]+; 1-(3,4-dimethoxyphenyl)-3-(N'-methylcarbamimidoyl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.786; MZMLKEGTPVWCMW-UHFFFAOYSA-N; [M+H]+; 1-(2,6-dimethoxyphenyl)-3-(N'-methylcarbamimidoyl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.780; PESRCCQMYJSHAV-UHFFFAOYSA-N; [M+H]+; 7-(3-hydroxybutyl)-1,3-dimethylpurine-2,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.713; FVYWRRDRUXVGII-UHFFFAOYSA-N; [M+H]+; 7-(2-hydroxybutyl)-1,3-dimethylpurine-2,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.713; WIZRYWWFTQBUAD-UHFFFAOYSA-N; [M+H]+; 7-(2-hydroxy-2-methylpropyl)-1,3-dimethylpurine-2,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.317; LKZJFSFXDGUCHF-UHFFFAOYSA-N; [M+H]+; 7-(3-hydroxybutan-2-yl)-1,3-dimethylpurine-2,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.312; AMTUSIQIVCNFIN-UHFFFAOYSA-N; [M+H]+; N-[[2-oxo-3-[(prop-2-enoylamino)methyl]imidazolidin-1-yl]methyl]prop-2-enamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -7.424; LNCFUHAPNTYMJB; [M+H]+; Histidylproline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -225.777; BEPSGCXDIVACBU; [M+H]+; ACMC-20lvdb
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -450.020; HBRFEPDAWBTTTH; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -514.023; NIAMBTSPHJKHDH; [M+H]+; 8-(4-Hydroxybutyl)theophylline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -515.164; ANNMVJZJFWYKHV; [M+H]+; 2-((4,6-Bis(allyloxy)-1,3,5-triazin-2-yl)amino)ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -564.497; FVYWRRDRUXVGII; [M+H]+; 7-(beta-Hydroxybutyl)theophylline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -571.953; PESRCCQMYJSHAV; [M+H]+; Theophylline, 7-(3-hydroxybutyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -580.078; GDEAMEURJBBCOQ; [M+H]+; Desmethyl-formamido-pirimicarb
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -581.590; LKZJFSFXDGUCHF; [M+H]+; Theophylline, 7-(2-hydroxy-1-methylpropyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -601.698; WIZRYWWFTQBUAD; [M+H]+; Theophylline, 7-(2-hydroxy-2-methylpropyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -609.737; SWLJVDNUQDIJCV; [M+H]+; 6-Cyclohexylamino-3-methyl-5-nitroso-1H-pyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -654.425; VIELBQDCCOCSMJ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.996; LNCFUHAPNTYMJB; [M+H]+; Histidylproline
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -101.179; LNCFUHAPNTYMJB; [M+H]+; 1-[2-azaniumyl-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -489.093; BEPSGCXDIVACBU; [M+H]+; 3-(1H-imidazol-5-yl)-2-[(pyrrolidin-2-yl)formamido]propanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -526.439; NIAMBTSPHJKHDH; [M+H]+; Theophylline, 8-(4-hydroxybutyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -569.348; PESRCCQMYJSHAV; [M+H]+; Theophylline, 7-(3-hydroxybutyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -581.890; FVYWRRDRUXVGII; [M+H]+; 7-(beta-Hydroxybutyl)theophylline
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -583.704; SWLJVDNUQDIJCV; [M+H]+; 6-(cyclohexylamino)-3-methyl-5-nitroso-1H-pyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -606.345; WIZRYWWFTQBUAD; [M+H]+; 1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-7-(2-hydroxy-2-methylpropyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -607.792; CIXVMNBTKMCQGI; [M+H]+; N-[[5-[(2S)-1-ethyl-5-oxopyrrolidin-2-yl]-1,2,4-oxadiazol-3-yl]methyl]acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -614.994; ANNMVJZJFWYKHV; [M+H]+; 2-((4,6-Bis(allyloxy)-1,3,5-triazin-2-yl)amino)ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -620.458; HBRFEPDAWBTTTH; [M+H]+; Ethyl N-{[(2-Aminopyridin-4-Yl)methyl]carbamoyl}glycinate
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.999; LNCFUHAPNTYMJB; [M+H]+; 1-[2-azaniumyl-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carboxylate
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match Histidinyl-Proline, LNCFUHAPNTYMJB-IUCAKERBSA-N; Matching to 3 measured spectra (Dot product > 0.7); Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0028893;
CH$NAME: Histidinyl-Proline
CH$NAME: (2S)-1-[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carboxylic acid
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C11H16N4O3
CH$EXACT_MASS: 252.122240
CH$SMILES: C1C[C@H](N(C1)C(=O)[C@H](CC2=CN=CN2)N)C(=O)O
CH$IUPAC: InChI=1S/C11H16N4O3/c12-8(4-7-5-13-6-14-7)10(16)15-3-1-2-9(15)11(17)18/h5-6,8-9H,1-4,12H2,(H,13,14)(H,17,18)/t8-,9-/m0/s1
CH$LINK: INCHIKEY LNCFUHAPNTYMJB-IUCAKERBSA-N
CH$LINK: PUBCHEM CID:152322
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 5.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 15.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 Âµm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min,` 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 0.824
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 253.128158
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-2900000000-7b2f22fd80ac18c4cdbc
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  70.0651770 61.1396 70.065327 15.6854 29.12 0.4831 10 f{C4H8N1}/0.73ppm,p-C7H9N3O3
  83.0597177 90.6563 83.059920 14.9290 38.41 0.4924 10 f{C4H7N2}/-7.91ppm,p-C7H10N2O3
  84.0805066 97.9035 84.080713 11.9766 36.18 0.2448 9 f{C5H10N1}/-3.20ppm,p-C6H7N3O3
  93.0454143 59.2273 93.045662 22.9135 23.51 0.7223 10 f{C5H5N2}/7.41ppm,p-C6H12N2O3
  110.0707495 999.0000 110.071085 5.6327 0.00 1.0000 10 f{C7H10O1}/-16.96ppm,p-C4H7N4O2
  116.0712624 43.0523 116.071632 11.5274 19.97 0.7277 10 f{C5H10N1O2}/5.66ppm,p-C6H7N3O1
  156.0768148 36.5172 156.077453 22.5786 14.61 0.5477 9 f{C11H10N1}/-25.38ppm,p-H7N3O3
  235.1201953 42.5117 235.122199 17.6548 22.98 0.2206 10 f{C11H15N4O2}/5.29ppm,p-H2O1
PK$NUM_PEAK: 8
PK$PEAK: m/z int. rel.int.
  70.065177 61.14 61
  83.059718 90.66 90
  84.080507 97.90 97
  93.045414 59.23 59
  110.070749 999.00 999
  116.071262 43.05 43
  156.076815 36.52 36
  235.120195 42.51 42
//
